Skip to content

13F-HR filed by First Turn Management, LLC

First Turn Management, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 15:05:28 UTC, with 38 holding rows worth $752,975,725.

Accession
0001993440-26-000005
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 38 entries on the cover page, a total value of $752,975,725 stated on the cover page (in dollars after the unit check, H1), rows summing to $752,975,725 with VALUE read as dollars as filed, 13F file number 028-23631. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ENLIVEN THERAPEUTICS INC COM29337E102Stock958,700$43,946,808dollars as filed
GUARDANT HEALTH INC COM40131M109Stock219,304$39,115,061dollars as filed
ABIVAX SA-00370M103SPONSORED ADS384,592$38,082,300dollars as filed
ROIVANT SCIENCES LTDG76279101SHS985,583$36,042,770dollars as filed
UNITED THERAPEUTICS CORP DEL COM91307C102Stock60,064$32,548,081dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM1,525,220$31,404,280dollars as filed
AXSOME THERAPEUTICS INC. COM05464T104Stock162,407$29,946,227dollars as filed
INSMED INC COM PAR $.01457669307Stock245,726$28,047,166dollars as filed
CELCUITY INC15102K100COM329,101$26,170,112dollars as filed
CHARLES RIV LABS INTL INC159864107COM86,801$25,607,163dollars as filed
CYTOKINETICS INC23282W605COM NEW357,945$23,592,155dollars as filed
BRIDGEBIO PHARMA INC10806X102COM354,371$23,317,612dollars as filed
PRAXIS PRECISION MEDICINES I74006W207COM NEW78,806$22,950,671dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM1,574,334$21,206,279dollars as filed
REPLIGEN CORP COM759916109Stock108,436$20,844,652dollars as filed
TANGO THERAPEUTICS INC87583X109COM766,860$19,133,157dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock92,316$18,948,782dollars as filed
INHIBRX BIOSCIENCES INC45720N103COM171,512$17,164,921dollars as filed
NEWAMSTERDAM PHARMA CO NVN62509109COMMON STOCK702,396$17,082,271dollars as filed
VERADERMICS INC922967104COMMON STOCK136,718$16,574,323dollars as filed
COGENT BIOSCIENCES INC19240Q201COM514,976$16,489,532dollars as filed
DIANTHUS THERAPEUTICS INC252828108COM178,573$15,723,353dollars as filed
PALVELLA THERAPEUTICS INC697947109COMMON STOCK109,871$15,154,507dollars as filed
RHYTHM PHARMACEUTICALS INC76243J105COM157,603$15,006,170dollars as filed
ARCUS BIOSCIENCES INC03969F109COM577,693$14,921,810dollars as filed
ARROWHEAD PHARMACEUTICALS IN04280A100COM222,649$14,572,377dollars as filed
DISC MEDICINE INC COM254604101Stock220,666$14,444,796dollars as filed
ERASCA INC COM29479A108Stock913,452$13,391,206dollars as filed
GRAIL INC384747101COM93,727$13,133,027dollars as filed
KYMERA THERAPEUTICS INC501575104COM113,299$12,665,695dollars as filed
ASCENDIS PHARMA A/SK08588103ORD SHS *A*54,594$12,438,151dollars as filed
UNIQURE NVN90064101SHS465,474$11,245,852dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock297,060$11,047,661dollars as filed
SPYRE THERAPEUTICS INC00773J202COM NEW102,541$9,129,225dollars as filed
SUMMIT THERAPEUTICS INC86627T108COM501,724$8,484,153dollars as filed
DEFINIUM THERAPEUTICS INC24477V105COM SHS216,531$8,241,170dollars as filed
VAXCYTE INC COM92243G108Stock137,534$7,825,685dollars as filed
HINGE HEALTH INC A433313103COMMON STOCK75,448$7,336,564dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001993440-26-000005this filing2026-11-16